Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Classifica tra le azioni #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Prezzo delle azioni
$47.54
Capitalizzazione di mercato
$69.46B
Variazione (1 giorno)
-3.59%
Variazione (1 anno)
-9.07%
Paese
DE
Scambia Sartorius Aktiengesellschaft (SOAGY)

Categoria

Ricavi di Sartorius Aktiengesellschaft (SOAGY)
Ricavi nel Dec 2025 TTM: $4.14B
Secondo gli ultimi rapporti finanziari di Sartorius Aktiengesellschaft, i ricavi attuali dell'azienda (TTM) sono pari a $4.14B. Nel 2023, l'azienda ha registrato ricavi di $3.75B una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $4.48B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Sartorius Aktiengesellschaft da 2002 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $4.14B 17.65%
2024 $3.52B -6.29%
2023 $3.75B -16.17%
2022 $4.48B 14.17%
2021 $3.92B 37.89%
2020 $2.84B 38.77%
2019 $2.05B 13.90%
2018 $1.80B 6.78%
2017 $1.69B 23.18%
2016 $1.37B 13.03%
2015 $1.21B 12.26%
2014 $1.08B -0.94%
2013 $1.09B -2.42%
2012 $1.12B 17.55%
2011 $949.02M 7.66%
2010 $881.50M 2.11%
2009 $863.31M 1.28%
2008 $852.37M -1.00%
2007 $860.99M 25.58%
2006 $685.60M 19.81%
2005 $572.23M -9.74%
2004 $633.99M 13.84%
2003 $556.93M 11.37%
2002 $500.05M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$10.06B 143.19%
US
$21.92B 429.71%
US
$5.91B 42.80%
JP
$10.40B 151.31%
CH
$5.40B 30.43%
US